Elevation Oncology Inc. (NASDAQ: ELEV) Stock Information | RedChip

Elevation Oncology Inc. (NASDAQ: ELEV) Listen to this Section


$0.71
-0.0102 ( -1.41% ) 539.1K

Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations. Its lead program is focused on neuregulin-1, or NRG1, fusions, which are rare genomic alterations that have the potential to be therapeutically actionable through targeted HER3 inhibition.

Market Data


Open


$0.71

Previous close


$0.72

Volume


539.1K

Market cap


$42.01M

Day range


$0.71 - $0.74

52 week range


$0.36 - $5.83

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
3 Insider transactions 2 Mar 04, 2024
4 Insider transactions 1 Mar 04, 2024
3 Insider transactions 2 Mar 04, 2024
4 Insider transactions 1 Feb 20, 2024
4 Insider transactions 1 Feb 20, 2024
4 Insider transactions 1 Feb 20, 2024
4 Insider transactions 1 Feb 20, 2024
8-k 8K-related 13 Jan 23, 2024
3 Insider transactions 2 Jan 22, 2024
8-k 8K-related 13 Jan 22, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.